75 mg for men who can also be getting other CNS depressants. No this kind of dose adjust is suggested for women. Keep away from use with other CNS depressants at bedtime; prevent use with Liquor. Take into account therapy modification
Identify your assortment: Title have to be below characters Choose a collection: Struggling to load your selection resulting from an error
butabarbital will lessen the level or result of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
butabarbital will lower the level or influence of tinidazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
The influence in the resultant reduced blood levels of griseofulvin on therapeutic reaction hasn't been established. Even so, It will be preferable to prevent concomitant administration of those medicine.
butabarbital will reduce the extent or impact of alfuzosin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
butabarbital decreases consequences of sufentanil SL by impacting check here hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of CYP3A4 inducers may well lower sufentanil amounts and efficacy, potentially precipitating withdrawal syndrome in people that have made Bodily dependence to sufentanil. Discontinuation of concomitantly utilized CYP3A4 inducers could increase sufentanil plasma concentration.
butabarbital will reduce the extent or influence of clozapine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
butabarbital will minimize the level or outcome of voriconazole by affecting hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Unfamiliar.
butabarbital will reduce the extent or result of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep an eye on.
butabarbital will lessen the level or effect of pantoprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
butabarbital will minimize the extent or impact of etravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
butabarbital and olopatadine intranasal both equally maximize sedation. Stay clear of or Use Alternate Drug. Coadministration increases risk of CNS despair, which may result in additive impairment of psychomotor effectiveness and lead to daytime impairment.
butabarbital will decrease the level or effect of conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.